Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb;21(2):150-151.
doi: 10.1016/S1473-3099(20)30870-7. Epub 2020 Nov 17.

Expecting the unexpected with COVID-19 vaccines

Naor Bar-Zeev  1 , Sonali Kochhar  2
Affiliations
Comment

Expecting the unexpected with COVID-19 vaccines

Naor Bar-Zeev et al. Lancet Infect Dis. 2021 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Le TT, Cramer JP, Chen R, Mayhew S. Evolution of the COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:667–668. - PubMed
    1. Zhang Y, Zheng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30843-4. published online Nov 17. - DOI - PMC - PubMed
    1. Kochhar S, Excler JL, Kim D, et al. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. Vaccine. 2020;38:6184–6189. - PMC - PubMed
    1. Fan C, Ye X, Ku Z, et al. Beta-propiolactone inactivation of coxsackievirus A16 induces structural alteration and surface modification of viral capsids. J Virol. 2017;91:e00038–e00117. - PMC - PubMed
    1. Delrue I, Verzele D, Madder A, Nauwynck HJ. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Expert Rev Vaccines. 2012;11:695–719. - PubMed

Substances